Guardant Health, Inc. - Common Stock (GH) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2018 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
GH on Nasdaq
Shares outstanding
123,850,680
Price per share
$102.14
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
122,494,871
Total reported value
$7,653,150,403
% of total 13F portfolios
0.01%
Share change
-1,731,398
Value change
-$62,643,329
Number of holders
387
Price from insider filings
$102.14
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Guardant Health, Inc. - Common Stock (GH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.5% $395,702,923 9,288,801 BlackRock, Inc. 31 Mar 2025
Deep Track Capital, LP 4.4% $231,902,515 5,443,721 Deep Track Capital, LP 31 Mar 2025
CADIAN CAPITAL MANAGEMENT, LP 4.2% $222,438,669 5,221,565 Cadian Capital Management, LP 31 Dec 2024
WELLINGTON MANAGEMENT GROUP LLP 3.9% $206,621,545 4,850,271 Wellington Management Group LLP 31 Dec 2024

As of 30 Sep 2025, 387 institutional investors reported holding 122,494,871 shares of Guardant Health, Inc. - Common Stock (GH). This represents 99% of the company’s total 123,850,680 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Guardant Health, Inc. - Common Stock (GH) together control 69% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9.6% 11,908,829 -2.1% 0.01% $744,063,636
BlackRock, Inc. 9.2% 11,429,315 +4.1% 0.01% $714,103,610
BAILLIE GIFFORD & CO 4.1% 5,127,692 +6.6% 0.24% $320,378,195
Invesco Ltd. 4% 4,929,543 +39% 0.05% $307,997,846
Capital International Investors 3.8% 4,689,241 -5.8% 0.05% $292,983,778
PRICE T ROWE ASSOCIATES INC /MD/ 3.4% 4,221,637 +139% 0.03% $263,769,000
Deep Track Capital, LP 3.4% 4,154,086 -2.3% 7.2% $259,547,293
EVENTIDE ASSET MANAGEMENT, LLC 2.7% 3,321,338 -4% 3.4% $207,506,637
WELLINGTON MANAGEMENT GROUP LLP 2.6% 3,249,085 +69% 0.04% $203,002,832
GEODE CAPITAL MANAGEMENT, LLC 2.4% 2,936,656 +0.55% 0.01% $183,509,854
FRANKLIN RESOURCES INC 2.4% 2,926,315 +26% 0.05% $182,836,178
STATE STREET CORP 2.3% 2,787,777 -1.8% 0.01% $174,180,307
FULLER & THALER ASSET MANAGEMENT, INC. 1.9% 2,369,568 +7.8% 0.5% $148,050,583
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 1.8% 2,261,869 -23% 0.03% $141,321,576
Driehaus Capital Management LLC 1.7% 2,152,315 -13% 0.96% $134,476,641
CADIAN CAPITAL MANAGEMENT, LP 1.7% 2,141,191 -33% 8% $133,781,614
TWO SIGMA ADVISERS, LP 1.7% 2,112,800 -11% 0.26% $132,007,744
Alyeska Investment Group, L.P. 1.5% 1,831,318 0.35% $114,420,749
TWO SIGMA INVESTMENTS, LP 1.5% 1,803,331 -2.8% 0.17% $112,672,121
FEDERATED HERMES, INC. 1.4% 1,776,369 +21% 0.2% $110,987,536
LORD, ABBETT & CO. LLC 1.2% 1,523,635 +72% 0.28% $95,197,000
GOLDMAN SACHS GROUP INC 1.2% 1,506,210 +31% 0.01% $94,108,001
RTW INVESTMENTS, LP 1.2% 1,481,033 +73% 1.1% $92,534,942
JENNISON ASSOCIATES LLC 1.2% 1,471,294 +106% 0.05% $91,926,448
UBS Group AG 1.2% 1,457,051 +23% 0.02% $91,036,546

Institutional Holders of Guardant Health, Inc. - Common Stock (GH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,659,917 $169,325,007 -$2,874,650 $102.14 50
2025 Q3 122,494,871 $7,653,150,403 -$62,643,329 $62.48 387
2025 Q2 124,295,969 $6,467,826,507 +$330,760,743 $52.04 359
2025 Q1 118,497,703 $5,048,167,769 +$16,676,833 $42.60 336
2024 Q4 119,502,850 $3,649,710,615 -$117,259,091 $30.55 294
2024 Q3 123,360,163 $2,828,395,562 +$157,249,709 $22.94 271
2024 Q2 114,860,413 $3,317,220,279 +$213,932,035 $28.88 283
2024 Q1 110,203,408 $2,271,988,357 -$27,655,375 $20.63 254
2023 Q4 748,091 $20,302,767 +$1,512,428 $27.05 3
2023 Q3 104,807,218 $3,106,579,186 -$95,119,352 $29.64 284
2023 Q2 106,577,868 $3,815,519,198 +$674,674,519 $35.80 287
2023 Q1 90,281,959 $2,115,043,258 +$62,505,835 $23.44 268
2022 Q4 92,066,296 $2,504,311,601 -$169,127,752 $27.20 277
2022 Q3 93,314,974 $5,020,169,674 +$79,975,536 $53.83 302
2022 Q2 92,152,917 $3,714,298,975 -$52,356,957 $40.34 305
2022 Q1 90,055,526 $5,952,513,377 -$86,974,490 $66.24 322
2021 Q4 91,798,770 $9,181,331,846 -$246,580,576 $100.02 371
2021 Q3 92,748,923 $11,592,589,112 +$572,773,065 $125.01 365
2021 Q2 89,439,043 $11,106,464,046 -$286,875,836 $124.19 407
2021 Q1 89,154,760 $13,609,100,786 +$675,853,171 $152.65 402
2020 Q4 85,744,254 $11,050,291,810 +$165,722,075 $128.88 389
2020 Q3 84,983,685 $9,499,367,930 +$181,194,087 $111.78 332
2020 Q2 82,733,811 $6,712,076,354 +$522,916,896 $81.13 302
2020 Q1 76,899,349 $5,351,713,753 +$250,521,871 $69.60 276
2019 Q4 76,929,898 $6,011,249,046 +$250,159,757 $78.14 254
2019 Q3 73,788,961 $4,709,899,224 -$154,901,989 $63.83 225
2019 Q2 75,845,046 $6,547,562,299 +$1,404,364,988 $86.33 210
2019 Q1 60,218,690 $4,616,675,723 +$11,832,372 $76.70 142
2018 Q4 61,703,846 $2,318,550,779 +$2,049,441,596 $37.59 86